| RS145900712 |
TONSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145901144 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS145901197 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS145901607 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS145901904 |
KCNJ5
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1459022689 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1459023925 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS145903082 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS145903120 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS1459031771 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS145903608 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1459036159 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145905497 |
TBK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, TBK1-related disorder |
| RS145906084 |
SLC12A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145906298 |
YARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, lactic acidosis |
| RS145906459 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD1-related disorder, Polycystic kidney disease |
| RS145906530 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Inborn genetic diseases |
| RS145906668 |
F11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS145906942 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145907585 |
TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Sarcotubular myopathy |
| RS145907618 |
CHRNG
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1459077847 |
NANS
|
Health Risk |
Pathogenic |
— |
| RS145908212 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis, Schimke immuno-osseous dysplasia |
| RS145909413 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS145910245 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS145910377 |
NALCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145910735 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, Inborn genetic diseases |
| RS1459110114 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1459123494 |
NCF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS145912433 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Knobloch syndrome, Knobloch syndrome |
| RS145912662 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, 6 conditions |
| RS145913500 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 2 |
| RS1459136471 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS1459137122 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS145913750 |
TMPRSS3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 8, Hearing loss |
| RS1459143051 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1459144096 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS1459151671 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1459158279 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS145916504 |
SLC16A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Exercise-induced hyperinsulinism, Exercise-induced hyperinsulinism |
| RS1459166839 |
NALCN
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS145918825 |
ACTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 15, Platelet-type bleeding disorder 15 |
| RS145919543 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, TTN-related disorder |
| RS145920072 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS145922241 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1459222478 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS145922845 |
IL10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease, Rheumatoid arthritis |
| RS145922879 |
TUBB1
|
Health Risk |
Conflicting classifications of pathogenicity |
TUBB1-related disorder, Macrothrombocytopenia |
| RS145923602 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Inborn genetic diseases |
| RS145924695 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart disease, Gorlin syndrome |
| RS1459252796 |
MTO1
|
Health Risk |
Likely pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS145925666 |
MAGI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome 15, Nephrotic syndrome 15 |
| RS145926679 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS1459266876 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1459270286 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1459273753 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS145928221 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS1459288402 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS145929061 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1459290952 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, GRIN2D-related disorder |
| RS145929269 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1459299108 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1459304265 |
F11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1459313694 |
PLVAP
|
Health Risk |
Pathogenic |
— |
| RS145931742 |
MANBA
|
Health Risk |
Likely pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1459317703 |
PROM1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1459322761 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS145932311 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, 6 conditions |
| RS1459326742 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS145933612 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Lethal acantholytic epidermolysis bullosa |
| RS1459339879 |
FGD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS145935225 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS145936354 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS145936761 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS1459369528 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Oculofaciocardiodental syndrome |
| RS1459374430 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Seizures |
| RS1459378570 |
BCS1L
|
Health Risk |
Likely pathogenic |
Mitochondrial complex III deficiency nuclear type 1, Mitochondrial complex III deficiency nuclear type 1 |
| RS145938212 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Inborn genetic diseases |
| RS1459382670 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS1459384589 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS145938865 |
VAC14
|
Health Risk |
Conflicting classifications of pathogenicity |
Striatonigral degeneration, childhood-onset |
| RS145939072 |
TMEM138
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 16, Joubert syndrome 16 |
| RS145939211 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS1459392243 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS145939391 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS145939548 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
DCHS1-related disorder, Familial cancer of breast |
| RS145939718 |
FLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145940009 |
DDOST
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation type Ir, DDOST-related disorder |
| RS145940356 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, TTN-related disorder |
| RS145940742 |
ASCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinal muscular atrophy with congenital bone fractures 2, ASCC1-related disorder |
| RS1459422877 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS145942328 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Acute aortic dissection |
| RS1459437890 |
PET100
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormality of the mitochondrion, Mitochondrial complex IV deficiency |
| RS145944049 |
ALX1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALX1-related disorder, ALX1-related disorder |
| RS1459441231 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1459452503 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome and related disorders |
| RS1459460059 |
ANO6
|
Health Risk |
Conflicting classifications of pathogenicity |
ANO6-related disorder, ANO6-related disorder |
| RS145946587 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS145946864 |
ARSL
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS145946881 |
MCM6
|
Health Risk |
association |
LACTASE PERSISTENCE, LACTASE PERSISTENCE |